APM

Avidity Partners Management Portfolio holdings

AUM $439M
1-Year Est. Return 34.53%
This Quarter Est. Return
1 Year Est. Return
+34.53%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$499M
AUM Growth
+$13.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
80
New
Increased
Reduced
Closed

Top Buys

1 +$16.7M
2 +$14.7M
3 +$13.5M
4
CGON icon
CG Oncology
CGON
+$13.5M
5
GMAB icon
Genmab
GMAB
+$13.4M

Top Sells

1 +$16.1M
2 +$13.2M
3 +$13.1M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$9.93M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$9.48M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEAM icon
26
Beam Therapeutics
BEAM
$2.2B
$6.96M 1.39%
409,400
-300,117
HUM icon
27
Humana
HUM
$28.5B
$6.75M 1.34%
27,600
-53,400
CATX icon
28
Perspective Therapeutics
CATX
$155M
$6.39M 1.27%
1,858,596
-338,674
OGN icon
29
Organon & Co
OGN
$1.96B
$6.2M 1.23%
640,000
+105,000
BBIO icon
30
BridgeBio Pharma
BBIO
$12.8B
$6.05M 1.2%
140,000
+65,000
INSM icon
31
Insmed
INSM
$41.2B
$5.94M 1.18%
59,000
-48,000
MDGL icon
32
Madrigal Pharmaceuticals
MDGL
$12B
$5.75M 1.15%
+19,000
RARE icon
33
Ultragenyx Pharmaceutical
RARE
$3.19B
$5.6M 1.12%
154,000
-168,100
CNTX icon
34
Context Therapeutics
CNTX
$107M
$4.9M 0.98%
7,477,255
+55
ORKA
35
Oruka Therapeutics
ORKA
$1.31B
$3.95M 0.79%
352,124
IMUX icon
36
Immunic
IMUX
$93.6M
$3.92M 0.78%
5,615,811
+1,161,403
ARQT icon
37
Arcutis Biotherapeutics
ARQT
$3.06B
$3.76M 0.75%
+268,000
DOCS icon
38
Doximity
DOCS
$9.34B
$3.68M 0.73%
60,000
-62,500
XENE icon
39
Xenon Pharmaceuticals
XENE
$3.15B
$3.38M 0.67%
107,891
-121,109
VRNA
40
DELISTED
Verona Pharma
VRNA
$3.2M 0.64%
+33,800
QURE icon
41
uniQure
QURE
$1.86B
$2.89M 0.57%
207,000
-129,200
APGE icon
42
Apogee Therapeutics
APGE
$4.47B
$2.82M 0.56%
+65,000
SLNO icon
43
Soleno Therapeutics
SLNO
$2.65B
$2.68M 0.53%
32,000
CAH icon
44
Cardinal Health
CAH
$48.8B
$2.52M 0.5%
+15,000
SPRY icon
45
ARS Pharmaceuticals
SPRY
$812M
$2.44M 0.49%
+140,000
KZR icon
46
Kezar Life Sciences
KZR
$45.3M
$2.3M 0.46%
502,600
NTLA icon
47
Intellia Therapeutics
NTLA
$1.01B
$2.18M 0.43%
+232,000
MLTX icon
48
MoonLake Immunotherapeutics
MLTX
$905M
$1.84M 0.37%
+39,000
ARVN icon
49
Arvinas
ARVN
$679M
$1.79M 0.36%
243,162
-170,000
SNDX icon
50
Syndax Pharmaceuticals
SNDX
$1.44B
$1.4M 0.28%
150,000
-775,000